A. Wright

发表

Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO / IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007.

A. Laszlo, A. Demuynck, M. Abdelaziz, 2003 .

Guidelines for surveillance of drug resistance in tuberculosis

M. Aziz, M. Espinal, M. Raviglione, 2009 .

Challenges in estimating the total burden of drug-resistant tuberculosis.

T. Cohen, M. Murray, C. Colijn, 2008, American journal of respiratory and critical care medicine.

Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.

R. Lumb, A. Van Deun, E. Kurbatova, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.

K. Floyd, A. Van Deun, M. Aziz, 2016, The New England journal of medicine.

Mycobacterium bovis Isolates with M. tuberculosis Specific Characteristics

S. Niemann, S. Rüsch-Gerdes, T. Kubica, 2006, Emerging infectious diseases.

Expanding culture and drug susceptibility testing capacity in tuberculosis diagnostic services: the new challenge.

M. Aziz, M. Raviglione, P. Nunn, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Second-line drug resistance in multidrug-resistant tuberculosis cases of various origins in the Netherlands.

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.

M. Aziz, A. Wright, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Does Current Drug Resistance Surveillance Provide Useful Information in Tuberculosis

T. Cohen, M. Murray, C. Colijn, 2009 .

Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.

A. Van Deun, K. Weyer, M. Zignol, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results

I. Bastian, K. Kam, L. Rigouts, 2009, Journal of Clinical Microbiology.

Worldwide Emergence of Extensively Drug-resistant Tuberculosis

G. Bai, R. Lumb, F. Drobniewski, 2007, Emerging infectious diseases.

Global incidence of multidrug-resistant tuberculosis.

Mehran Hosseini, Brian G. Williams, Christopher Dye, 2006, The Journal of infectious diseases.

Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229)

C. Dye, M. Aziz, B. Williams, 1998 .

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

K. Kam, P. Small, M. Yagui, 2008 .

Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis

Paul Nunn, M. Aziz, F. Portaels, 2006, The Lancet.

Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.

H. Blumberg, A. Wright, V. Mirtskhulava, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

K. Kam, D. Falzon, F. Drobniewski, 2009, The Lancet.

Patients with previously treated tuberculosis no longer neglected.

M. Raviglione, P. Nunn, E. Jaramillo, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.

M. Aziz, G. Orefici, E. Iona, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Are Survey-Based Estimates of the Burden of Drug Resistant TB Too Low? Insight from a Simulation Study

T. Cohen, M. Murray, C. Colijn, 2008, PloS one.

The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan.

S. Niemann, M. Aziz, S. Rüsch-Gerdes, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tb drug resistance: is it really a threat to Africa?

P. Nunn, H. Getahun, E. Jaramillo, 2007, Ethiopian medical journal.

GUIDELINES FOR SURVEILLANCE OF DRUG RESISTANCE IN TUBERCULOSIS

M. Aziz, M. Espinal, M. Raviglione, 2003 .